Topical Steroid Withdrawal: The Proposed Mechanisms, What's Accepted vs Contested & What to Do
Topical steroid withdrawal is one of the most discussed and most contested topics in the eczema and skin condition community. Online, accounts of severe, debilitating symptoms following the reduction or cessation of topical corticosteroids have generated significant attention and, for many people, significant anxiety about using steroids at all.
This article aims to present an honest account of where the evidence stands — what is well-established, what is genuinely debated, and what this means practically. It is not intended to encourage stopping topical steroid treatment — that decision should always involve a healthcare professional — but to help people who are experiencing or concerned about severe reactions to steroid cessation understand what may be happening and what to do about it.
Topical Steroid Withdrawal (TSW): Why It’s Becoming More Discussed
Topical steroid withdrawal — often shortened to TSW — has become one of the most talked-about topics in the eczema and skin health community.
Many people describe experiencing severe redness, burning, peeling and skin sensitivity after stopping long-term topical steroid use. Others question whether these symptoms are always true “withdrawal” or simply severe eczema returning.
Because of this, topical steroid withdrawal remains controversial and emotionally charged — especially online. But regardless of the debate, many people experiencing intense flare-ups after steroid use are searching for ways to support their skin barrier and overall skin comfort.
Many people experiencing TSW describe skin that feels extremely reactive, inflamed and difficult to calm
What topical corticosteroids are and how they work
Topical corticosteroids (TCS) are anti-inflammatory medications applied to the skin. They have been used for over 60 years and are among the most effective and most prescribed treatments for eczema, psoriasis, and other inflammatory skin conditions. Applied appropriately — at the right potency, to the right area, for the right duration — they are safe and effective.
Concerns arise with prolonged use of moderate-to-high potency steroids, particularly on sensitive areas (face, skin folds), and in people who have used them continuously for months or years. Well-established side effects of topical steroid misuse include: skin thinning (atrophy), telangiectasia (permanent small dilated blood vessels), striae (stretch marks), perioral dermatitis, and — with very high-potency preparations over large areas — systemic cortisol suppression.
These side effects are recognised, documented, and not contested. They are distinct from the more debated phenomenon of TSW.
What topical steroid withdrawal is — and what's contested
Topical steroid withdrawal (TSW), also referred to as "Red Skin Syndrome" (RSS) and formally proposed by the International Topical Steroid Addiction Network (ITSAN), describes a distinct pattern of symptoms following the reduction or cessation of topical corticosteroids in people who have used them for extended periods.
Proposed characteristics of TSW include: burning rather than itching (which people with eczema typically describe as the predominant symptom); erythema (redness) that extends well beyond the original eczema distribution; a "red sleeve" pattern — diffuse redness across the limbs; skin sensitivity to previously tolerated products; temperature dysregulation; oozing and crusting; and a symptom pattern that is significantly worse than any previous eczema presentation.
What is genuinely contested: the medical community is not unified on TSW. Some dermatologists accept it as a real iatrogenic (medically caused) condition; others argue that reported TSW is primarily uncontrolled eczema returning — sometimes more severely because underlying disease was undertreated or because steroid-dependent eczema was masked rather than resolved. The debate is compounded by the difficulty of distinguishing TSW from severe eczema rebound, and by the emotive online discourse that surrounds the topic.
The Cochrane reviews and major dermatological bodies (British Association of Dermatologists, American Academy of Dermatology) have not formally recognised TSW as a distinct diagnostic entity, though several case series and case reports do describe the clinical picture consistently enough to take seriously
Symptoms Commonly Linked To TSW
People discussing TSW often describe:
Burning rather than itching
Bright red or “raw” skin
Extreme sensitivity to products
Temperature regulation issues
Flaking and peeling
Difficulty sleeping
Skin oozing or cracking
Some people also report:
Fatigue
Stress and anxiety
Social withdrawal due to visible skin symptoms
Skin barrier disruption appears to play a major role in many TSW experiences.
The proposed mechanism
Why might TSW occur? The most coherent proposed mechanism involves two physiological adaptations to prolonged steroid exposure:
Glucocorticoid receptor downregulation. Prolonged exposure to exogenous corticosteroids causes the skin's glucocorticoid receptors to become less responsive — a process called desensitisation or downregulation. When the steroid is removed, the skin loses both its treatment effect and its adapted regulatory state simultaneously, producing an inflammatory rebound.
Adrenergic rebound vasodilation. Topical steroids cause vasoconstriction (narrowing of blood vessels). With prolonged use, blood vessel smooth muscle becomes adapted to this vasoconstricted state. When steroids are stopped, rebound vasodilation occurs — producing the diffuse redness and "burning" heat that are among the most characteristic TSW reports, and distinguishing it from the more typical itch-predominant presentation of eczema.
These mechanisms are plausible and consistent with the clinical picture described by people who report TSW. They are not yet fully validated in prospective controlled research, which is why the debate continues.
Common Triggers That May Worsen TSW Symptoms
People with highly reactive skin often notice worsening symptoms from:
Heat and sweating
Fragrance
Harsh skincare products
Over-cleansing
Stress
Rough fabrics
Sensitive skin may also become more reactive to products that previously caused no problems.
Simplifying skincare routines is often one of the first approaches people try.
Who is most at risk
Based on case series and the proposed mechanisms, TSW is most associated with:
Prolonged use of moderate-to-high potency topical steroids (Groups 2–4 on the UK potency scale), typically for months to years. Use on areas of thin or sensitive skin — particularly the face, neck, and genitals, where absorption is highest. Use that has expanded beyond the original affected area. Steroid use that has become necessary for daily comfort rather than used intermittently for flares as intended.
This pattern — escalating reliance on increasingly potent steroids applied to expanding areas for daily comfort — is the clinical scenario most associated with TSW reports, and is also a pattern that dermatologists would identify as inappropriate use that should be addressed regardless of whether TSW is accepted as a distinct condition.
Why Stress & Sleep Often Become Bigger Problems
TSW symptoms can be physically and emotionally exhausting.
Many people report:
Difficulty sleeping
Increased anxiety
Stress-related flare-ups
Emotional burnout
And because stress itself may worsen skin inflammation and itching, the cycle can become difficult to break.
Skin health and emotional wellbeing are often closely connected during severe flare-ups.
What to do if you think you may have TSW
The most important point: do not stop topical steroids suddenly without medical advice. Abrupt cessation after prolonged high-potency use can trigger severe rebound flaring. Any reduction in topical steroid use should be planned and supervised. Tapering — gradually reducing frequency and then potency — is the standard approach.
Discuss with your GP or dermatologist. If you believe your steroid use has become excessive, the right response is a medical conversation — not self-managed cessation. Your doctor can assess whether your current use is appropriate, plan a tapering protocol if needed, and introduce steroid-sparing alternatives (calcineurin inhibitors, dupilumab for eligible patients) to reduce steroid burden while maintaining disease control.
Be cautious about online TSW communities. The lived experience shared in these communities is real and shouldn't be dismissed. But they can also amplify fear and encourage steroid cessation that is premature or dangerous for people with significant underlying disease. Individual experiences are not generalisable, and what is presented as TSW is sometimes undertreated eczema.
If symptoms are severe and you have recently stopped steroids, seek medical review. A dermatologist can assess whether the pattern is consistent with TSW, rebound eczema, or another condition, and provide appropriate management.
Supplement Support for Dry, Sensitive Skin
Nutritional status is relevant during any severe inflammatory skin period. Vitamin D levels are commonly low in people with eczema and psoriasis; zinc supports immune regulation and skin barrier repair; magnesium helps regulate the stress response that amplifies skin inflammation.
Drought's Skin Support Formulaprovides 14 nutrients including vitamin D, zinc, vitamin C, and magnesium — supporting the internal nutritional foundations during any period of significant skin inflammation. Made in the UK, suitable for vegetarians, designed for consistent long-term daily use. It works alongside appropriate medical treatment rather than as a replacement for it.
Supporting skin during steroid reduction and recovery
Whether recovering from TSW, tapering steroid use, or managing very reactive skin, the skincare principles are consistent:
Absolute minimum product use. Severely reactive skin overwhelmed by multiple products needs simplification, not escalation. One gentle, fragrance-free emollient consistently applied is more effective than six products applied inconsistently.
Fragrance-free throughout. Contact sensitisation is more common in people who have used many topical products over years of skin condition management. Fragrance in any form is the most common contact allergen and should be eliminated completely during sensitive periods.
Temperature management. Heat and sweating worsen the vasodilatory component of TSW-like symptoms. Cool rooms, light breathable clothing, and cooling the skin with damp cloths during burning episodes provide comfort without adding further products.
Mental health support. TSW — or severe eczema rebound — is physically and psychologically exhausting. The NHS IAPT programme provides CBT-based psychological support; the Eczema Society and Psoriasis Association offer peer support. Isolation during severe flares worsens psychological outcomes and increases stress-driven skin inflammation.
FAQ
What is topical steroid withdrawal?
Topical steroid withdrawal (TSW) — also called topical corticosteroid withdrawal or red skin syndrome — refers to a cluster of severe skin symptoms some people experience after stopping or reducing long-term topical corticosteroid use. It sits in a genuinely contested area between two recognised phenomena: rebound dermatitis (well-established — skin worsening when steroids are stopped) and a distinct iatrogenic withdrawal syndrome (proposed but without formal medical consensus). The proposed mechanism involves cutaneous blood vessel dependence on topical steroid-mediated vasoconstriction — when steroids are withdrawn, vasodilation produces the characteristic burning erythema that extends beyond the original treatment area. The debate is not about whether severe symptoms occur after steroid cessation — they do, consistently enough to take seriously — but about whether these represent a distinct syndrome or severe rebound of the underlying condition.
What helps during TSW or severe steroid rebound?
Minimal products, fragrance-free emollient as the only skincare, temperature management, and medical supervision. Mental health support is important given the psychological impact of severe skin symptoms.
Can topical steroids be used safely?
Yes — when used at the appropriate potency, for the appropriate duration, on appropriate skin areas, with medical guidance. The problems arise with extended use of potent preparations on thin skin or large areas without adequate review.
What are common TSW symptoms?
Commonly reported symptoms include burning (rather than itching), diffuse redness extending beyond original eczema sites, "red sleeve" patterns on limbs, extreme product sensitivity, temperature dysregulation, and oozing or crusting — often worse than any previous eczema presentation.
Is TSW real?
The International Topical Steroid Awareness Network (ITSAN) has documented thousands of case reports with consistent symptom patterns that suggest a genuine phenomenon beyond simple rebound. Several dermatological bodies have begun acknowledging TSW as a clinical concern worthy of further research — the position is shifting from outright dismissal toward cautious acceptance of its existence while the mechanisms and prevalence remain under investigation.
Which topical steroids carry the highest TSW risk?
Higher potency, longer duration, and larger body surface area application all increase TSW risk — but no threshold has been established below which the risk is definitively zero. The highest-risk presentations in case reports involve potent to very potent steroids (Betamethasone valerate, Clobetasol propionate) used daily for months to years on the face, genitals, or large body areas. The face and genitals are the highest-risk sites — thinner skin allows greater systemic absorption and greater local vascular dependence. Mild to moderate potency steroids (hydrocortisone 1%, Eumovate) used intermittently for short courses on body areas carry considerably lower risk. The practical guidance is consistent with standard prescribing: use the lowest effective potency for the shortest necessary duration, with regular clinical review for anyone using moderate or above potency preparations for more than two to four weeks continuously.
Does TSW affect mental health?
Significantly — and this dimension is consistently underrepresented in clinical discussions of TSW. The combination of severe visible skin changes, extreme discomfort, product sensitivity preventing normal skincare routines, sleep disruption from burning and temperature dysregulation, and the contested medical status that means some patients feel dismissed by healthcare providers produces a specific and severe psychological burden. Published quality-of-life assessments of people reporting TSW consistently show high rates of anxiety, depression, and social withdrawal — comparable to or exceeding the psychological burden of severe atopic eczema. GP discussion about mental health support — referral to IAPT for CBT, or to a dermatology-specialist psychologist where available — is an appropriate and important part of management for anyone experiencing severe symptoms, regardless of whether the phenomenon is classified as TSW or severe steroid rebound.
How long does topical steroid withdrawal last?
Recovery timelines vary enormously in reports — from weeks to years depending on duration of steroid use, potency, and affected area. This variability itself reflects the contested nature of the phenomenon.
Can moisturising help TSW?
Yes — but with specific caveats that distinguish TSW management from standard eczema moisturising. Many people experiencing TSW or severe steroid rebound report extreme sensitivity to products they previously tolerated — including fragranced and even some fragrance-free emollients. The most consistently recommended approach is a minimal single-ingredient or near-single-ingredient emollient — plain petroleum jelly or a very short ingredient list fragrance-free cream — applied gently without friction. Wet wrapping and occlusive dressings help some people manage the burning and temperature dysregulation. The principle is the same as eczema barrier support — reduce TEWL, protect the compromised surface, avoid additional sensitisers — but the implementation requires significantly more caution around product selection given the heightened reactivity during this period.
Should you stop topical steroids suddenly?
Not without medical advice. Abrupt cessation after prolonged high-potency use can trigger severe rebound. Discuss concerns with your GP or dermatologist; any reduction should be planned, supervised, and gradual.
Summary
Topical steroid withdrawal is a genuinely contested topic where lived experience, clinical observation, and formal medical recognition have not yet aligned. What is clear: prolonged inappropriate steroid use causes real problems, whether framed as TSW or as dependence and barrier damage; abrupt cessation without medical supervision is not safe; and the symptoms people describe as TSW — burning, widespread redness, extreme sensitivity — represent genuine suffering that deserves to be taken seriously rather than dismissed. The appropriate response is a supervised reduction with medical guidance, steroid-sparing alternatives where appropriate, and the gentlest possible skincare during what is, however it's labelled, a period of significant skin vulnerability.
Written by the Drought Skin team — specialists in natural support for psoriasis, eczema and acne
Disclaimer: This article contains affiliate links. We earn a very small commission from each purchase made through these links. There is no additional cost to you. All products featured have been specifically selected as products we personally use and love. For further information, please see our disclaimer page.
